Drug intelligence / Profile preview

CongRongShuJing

Development stage: Unknown
Lead developer: Fujian University of Traditional Chinese Medicine
Administration: Oral

Overview

CongRongShuJing (also referred to as CongRongShuJing Prescription) is a Traditional Chinese Medicine (TCM) herbal formula developed by the Fujian University of Traditional Chinese Medicine. The prescription is specifically designed to target muscle tension and rigidity, which are common motor symptoms in patients with Parkinson's disease. The name 'CongRong' refers to *Cistanche deserticola*, a key herbal component known in TCM for its tonifying and neuroprotective effects, while 'ShuJing' translates to 'relaxing the tendons or muscles.' Clinical research, including trials registered in the Chinese Clinical Trial Registry (ChiCTR), has focused on evaluating its efficacy and safety as an adjunctive therapy to standard Parkinson's treatments.

Other names: CongRongShuJing Prescription

Beyond the preview

Go deeper on CongRongShuJing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CongRongShuJing.

Explore the full profile